The VDR variants observed were TaqI (rs731236), in 30 patients with MS (85.7%), 11 individuals with other AIDs (84.6%), and in 35 unaffected individuals (76.1%); and FokI (rs2228570) in 30 patients with MS (85.7%), 12 individuals with other AIDs (85.7%), and in 41 unaffected individuals (89.1%). The gene discussed is VDR; the disease is myeloid sarcoma.